VM
NVRO

Venator Management’s NEVRO CORP. NVRO Stock Holding History

Venator Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,000
Closed -$217K – 31
2024
Q1 		$217K Sell
15,000
-20,000
-57% -$331K 0.06% 28
2023
Q4 		$753K Buy
35,000
+10,000
+40% +$178K 0.25% 26
2023
Q3 		$481K Hold
25,000
– – 0.18% 26
2023
Q2 		$636K Buy
+25,000
New +$722K 0.23% 25

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Venator Management's NVRO Position: Q2 2024 in Review

Venator Management sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 15,000 shares — an estimated $217K sold.

Venator Management first reported a position in NVRO in Q2 2023 and held it in 4 quarters. The position peaked at $753K in Q4 2023. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • Venator Management reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • Venator Management sold 15,000 NEVRO CORP. shares in Q2 2024, an estimated $217K.
  • Venator Management first reported a position in NEVRO CORP. in Q2 2023 and held it in 4 quarters.
  • Venator Management's NEVRO CORP. position peaked at $753K in Q4 2023.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on Venator Management's 13F filing for Q2 2024, filed 12 Aug 2024.